Tennessee Oncology, PLLC - Chattanooga Med Park II — Chattanooga, Tennessee

Tennessee Oncology, PLLC - Chattanooga Med Park II is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Tennessee Oncology, PLLC - Chattanooga Med Park II has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chattanooga

Browse all research sites in Tennessee · View every site in Chattanooga

• University of Tennessee/Erlanger Oncology and Hematology
• University of Tennessee Erlanger Cardiology
• University Oncology/ Hematology Associates
• Center for Sports Medicine and Orthopaedics; Memorial Hospital
• Children's Hospital at Erlanger
• University of Tennessee-Chattanooga Unit
• University Oncology and Hematology Associates
• Memorial Hospital
• University of Diabetes and Endocrine Consultants
• University Diabetes & Endocrine Consultants /ID# 170392
• University of Tennessee Erlanger Oncology & Hematology
• Parkridge East Hospital

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology, PLLC - Chattanooga Med Park II?

Tennessee Oncology, PLLC - Chattanooga Med Park II has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology, PLLC - Chattanooga Med Park II conducted?

Tennessee Oncology, PLLC - Chattanooga Med Park II has 4 clinical trials on record, with 4 currently active. Their work covers Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma.

Is Tennessee Oncology, PLLC - Chattanooga Med Park II accredited by Crixeo Clinical Trials?

Tennessee Oncology, PLLC - Chattanooga Med Park II has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology, PLLC - Chattanooga Med Park II?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.